Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

There is no significant link between male pattern baldness and insulin resistance.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Mutations in certain receptors can cause diseases and offer new treatment options.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Many Korean patients with hair loss, skin allergies, and psoriasis use alternative medicine, but satisfaction is low.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Finasteride reverses early hair loss and promotes growth.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.